In newborns at risk of congenital toxoplasmosis, with positive IgG and negative IgM and IgA tests, a comparative mother-infant Western blot (WB) allows the early detection of synthesized neonatal antibodies, which have different antigenic specificity from maternal ones (66). Here, CD79A is linked to congenital toxoplasmosis.